Non-Member Access fee for Recorded CE Webinar:
Pharmacy DIR Fees; A National Landscape
Non-members are invited to view recorded webinars and receive CE credit for a small fee.
Once your payment has been processed, you will receive an automated email with a link to download an electronic item. Click the link in the email - this will download a PDF file that contains a link to access the recorded webinar.
Please contact PPA's CPE Administrator, Sara Powers, at (717) 234-6151 x. 2 or firstname.lastname@example.org with questions.
Please read the following information about this continuing pharmacy education (CPE) activity before purchasing.
Release Date: September 29, 2016
Expiration Date: September 29, 19
Activity Type: Knowledge-based
CE Credit: 1 Contact Hour (0.1 CEU)
Cost: Free for PPA members! $30 for non-members.
|The Pennsylvania Pharmacists Association is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy education.
Registered Pharmacists, Pharmacy Owners
DIR stands for “direct and indirect remuneration” and are also referred to as “network to plan rebates.” DIR was initially coined by the Centers for Medicare and Medicaid Services (CMS) related to the Medicare Part D benefit to address price concessions (e.g. drug manufacturer rebate). Essentially, rates are established in which corresponding fees are often taken out of pharmacy reimbursements. Unfortunately, these fees can be very confusing and have a history of hurting independent and/or retail pharmacies’ income. PPA has partnered with the National Community Pharmacists Association (NCPA) to put together a webinar that covers everything pharmacists need to know about DIR fees and how to manage them!
Please note this presentation will not include contracting or business advice on third party or insurance payer contracts, including acceptance or rejection, as such would be in violation of antitrust laws. The presentation and all discussions and questions will be conducted in accordance with antitrust laws and PPA’s antitrust policy.
1. Explain Direct and Indirect Remuneration Fees (DIR)
2. Identify common types of DIR fees
3. Describe CMS proposed guidance to address DIR fees at POS
4. Determine the impact of DIR fees on patients and pharmacies
5. Describe steps being taken by congress to address DIR fees
Ronna Hauser, Vice President Pharmacy Affairs, NCPA
Ronna B. Hauser, PharmD, is Vice President of Pharmacy Affairs for the National Community Pharmacists Association (NCPA). In this capacity Ronna is responsible for the association’s professional affairs, public policy and regulatory initiatives. Prior to NCPA, Ronna was the Director of Pharmacy Advocacy and Policy at the National Association of Chain Drug Stores, where she advocated the value of pharmacy to federal and state legislators, regulators, and other policymakers. She also works as a licensed community pharmacist.
||Susan Pilch, Vice President Policy and Regulatory Affairs, NCPA Susan Pilch is the Vice President of Policy and Regulatory Affairs for the National Community Pharmacists Association (NCPA). Prior to this position, she worked as a multi-state lobbyist representing primary wholesale pharmaceutical distributors as well as served as Director of state legislative and regulatory advocacy for another health-related professional association.
||Matt DiLoreto, Senior Director State Government Affairs, NCPA
Matthew DiLoreto is the Senior Director of State Government Affairs at the National Community Pharmacists Association (NCPA). In his role at NCPA, Mr. DiLoreto coordinates with state and federal partners to advance community pharmacy initiatives at the state and federal levels and represents NCPA’s interest in all states across the nation. Mr. DiLoreto’s efforts have largely focused on promoting reforms over the Pharmacy Benefit Manager (PBM) and retail pharmacy marketplace.
This Webinar comprises members from various pharmacy stakeholder organizations and may, in its course of business, legally and quite properly engage in a variety of activities and discussions. However, antitrust considerations require that attendees of this Webinar observe the following guidelines:
Attendees and presenters may not discuss or exchange information regarding:
a. Individual company prices, price changes, price differentials, markups, discounts, allowances, credit terms, etc.
b. Individual company figures on costs, inventories, sales, etc.
c. Industry pricing policies, price levels, price changes, differentials, etc.
d. Matters relating to actual or potential individual suppliers that might have the effect of excluding them from any market or of influencing the business conduct of firms toward such suppliers or customers.
e. Bids on contracts for particular products and/or services
This Webinar discussion will be limited to agenda topics relating to the national policy and legislative matters of the overall Webinar subject matter.
To receive CE credit for this home study, you will need to watch the entire video, complete an online survey evaluation, and pass a short quiz. Access to the survey and quiz will be automatically provided after you have watched the video. PPA must have your CPE Monitor ID and birthday on file to issue credit.